Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Capital Leases (2017 - 2019)

Phibro Animal Health has reported Capital Leases over the past 3 years, most recently at $40000.0 for Q2 2019.

  • For Q2 2019, Capital Leases fell 66.1% year-over-year to $40000.0; the TTM value through Jun 2019 reached $40000.0, down 66.1%, while the annual FY2019 figure was $40000.0, 66.1% down from the prior year.
  • Capital Leases for Q2 2019 was $40000.0 at Phibro Animal Health, down from $60000.0 in the prior quarter.
  • Over five years, Capital Leases peaked at $182000.0 in Q3 2017 and troughed at $40000.0 in Q2 2019.
  • A 3-year average of $110625.0 and a median of $108500.0 in 2018 define the central range for Capital Leases.
  • Biggest five-year swings in Capital Leases: tumbled 45.6% in 2018 and later crashed 66.1% in 2019.
  • Year by year, Capital Leases stood at $166000.0 in 2017, then plummeted by 53.61% to $77000.0 in 2018, then tumbled by 48.05% to $40000.0 in 2019.
  • Business Quant data shows Capital Leases for PAHC at $40000.0 in Q2 2019, $60000.0 in Q1 2019, and $77000.0 in Q4 2018.